Germline Mutations inHOXB13and Prostate-Cancer Risk
Author(s) -
Charles M. Ewing,
Anna M. Ray,
Ethan M. Lange,
Kimberly A. Zuhlke,
Christiane M. Robbins,
Waibhav Tembe,
Kathleen E. Wiley,
Sarah D. Isaacs,
Dorhyun Johng,
Yunfei Wang,
Chris Bizon,
Guifang Yan,
Marta Gielzak,
Alan W. Partin,
Vijayalakshmi Shanmugam,
Tyler Izatt,
Shripad Sinari,
David W. Craig,
S. Lilly Zheng,
Patrick C. Walsh,
James E. Montie,
Jianfeng Xu,
John D. Carpten,
William B. Isaacs,
Kathleen A. Cooney
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1110000
Subject(s) - prostate cancer , medicine , germline mutation , prostate , proband , cancer , oncology , germline , family history , mutation , genetics , risk factor , biology , gene
Family history is a significant risk factor for prostate cancer, although the molecular basis for this association is poorly understood. Linkage studies have implicated chromosome 17q21-22 as a possible location of a prostate-cancer susceptibility gene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom